According to OPKO Health 's latest financial reports the company's total debt is $0.32 B. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2023-12-31 | $0.32 B | 6.88% |
2022-12-31 | $0.30 B | 19.94% |
2021-12-31 | $0.25 B | -13.52% |
2020-12-31 | $0.29 B | -6.77% |
2019-12-31 | $0.31 B | 48.02% |
2018-12-31 | $0.21 B | 35.11% |
2017-12-31 | $0.15 B | 49.83% |
2016-12-31 | $0.10 B | -29.58% |
2015-12-31 | $0.14 B | 1.63% |
2014-12-31 | $0.14 B | -35.3% |
2013-12-31 | $0.22 B | 904.34% |
2012-12-31 | $22.67 M | 158.95% |
2011-12-31 | $8.75 M | -40.39% |
2010-12-31 | $14.69 M | -25.29% |
2009-12-31 | $19.66 M | 42.58% |
2008-12-31 | $13.79 M | -3.13% |
2007-12-31 | $14.23 M | |
2002-12-31 | $0.2 M | 0% |
2001-12-31 | $0.2 M |
Company | Total debt | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $29.33 B | 8,882.01% | ๐บ๐ธ USA |
Abbott Laboratories ABT | $15.62 B | 4,685.59% | ๐บ๐ธ USA |
Regeneron Pharmaceuticals REGN | $2.70 B | 727.68% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $41.46 B | 12,597.05% | ๐บ๐ธ USA |
LabCorp LH | $5.95 B | 1,723.29% | ๐บ๐ธ USA |
Alnylam Pharmaceuticals
ALNY | $1.30 B | 299.73% | ๐บ๐ธ USA |
Teva Pharmaceutical Industries TEVA | $20.15 B | 6,071.23% | ๐ฎ๐ฑ Israel |
Ardelyx ARDX | $55.98 M | -82.86% | ๐บ๐ธ USA |